Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO

Clinical trial NCT07152392 · RECRUITING

Trial details

NCT number: NCT07152392
Sponsor: Shanghai Changzheng Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Thyroid Associated Ophthalmopathies

Start date: 2025-04-15
Primary completion: 2027-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.